Am J Epidemiol. 2021 Nov 2;190(11):2384-2394. doi: 10.1093/aje/kwab149.
The prevalence of ideal cardiovascular health (CVH) among adults in the United States is low and decreases with age. Our objective was to identify specific age windows when the loss of CVH accelerates, to ascertain preventive opportunities for intervention. Data were pooled from 5 longitudinal cohorts (Project Heartbeat!, Cardiovascular Risk in Young Finns Study, The Bogalusa Heart Study, Coronary Artery Risk Development in Young Adults, Special Turku Coronary Risk Factor Intervention Project) from the United States and Finland from 1973 to 2012. Individuals with clinical CVH factors (i.e., body mass index, blood pressure, cholesterol, blood glucose) measured from ages 8 to 55 years were included. These factors were categorized and summed into a clinical CVH score ranging from 0 (worst) to 8 (best). Adjusted, segmented, linear mixed models were used to estimate the change in CVH over time. Among the 18,343 participants, 9,461 (52%) were female and 12,346 (67%) were White. The baseline mean (standard deviation) clinical CVH score was 6.9 (1.2) at an average age of 17.6 (8.1) years. Two inflection points were estimated: at 16.9 years (95% confidence interval: 16.4, 17.4) and at 37.2 years (95% confidence interval: 32.4, 41.9). Late adolescence and early middle age appear to be influential periods during which the loss of CVH accelerates.
美国成年人理想心血管健康(CVH)的流行率较低,且随年龄增长而降低。我们的目标是确定 CVH 丧失加速的特定年龄窗口,以确定干预的预防机会。数据来自美国和芬兰的 5 个纵向队列(Project Heartbeat!、心血管风险在年轻芬兰人研究、Bogalusa 心脏研究、年轻人冠状动脉风险发展、特殊图尔库冠状动脉风险因素干预项目),这些队列的数据收集时间从 1973 年至 2012 年。纳入的个体具有从 8 岁到 55 岁测量的临床 CVH 因素(即体重指数、血压、胆固醇、血糖)。这些因素进行分类并汇总为一个临床 CVH 评分,范围从 0(最差)到 8(最佳)。使用调整后的分段线性混合模型来估计 CVH 随时间的变化。在 18343 名参与者中,9461 名(52%)为女性,12346 名(67%)为白人。平均基线(标准差)临床 CVH 评分为 6.9(1.2),平均年龄为 17.6(8.1)岁。估计有两个拐点:16.9 岁(95%置信区间:16.4,17.4)和 37.2 岁(95%置信区间:32.4,41.9)。青少年晚期和中年早期似乎是 CVH 丧失加速的重要时期。